Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1872 1
1882 1
1888 1
1895 2
1897 1
1900 1
1909 1
1946 1
1951 1
1952 1
1953 2
1954 1
1955 1
1956 1
1957 2
1958 1
1959 2
1960 4
1962 1
1963 4
1964 1
1965 2
1966 5
1967 8
1968 8
1969 9
1970 7
1971 8
1972 12
1973 16
1974 15
1975 10
1976 11
1977 9
1978 9
1979 5
1980 6
1981 13
1982 18
1983 23
1984 17
1985 14
1986 12
1987 11
1988 19
1989 8
1990 8
1991 16
1992 19
1993 16
1994 18
1995 15
1996 12
1997 13
1998 18
1999 10
2000 10
2001 16
2002 13
2003 7
2004 10
2005 11
2006 7
2007 11
2008 16
2009 12
2010 25
2011 17
2012 16
2013 17
2014 23
2015 17
2016 31
2017 26
2018 31
2019 25
2020 36
2021 47
2022 53
2023 39
2024 45
2025 53

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,000 results

Results by year

Filters applied: . Clear all
Page 1
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.
Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez-Cruzan M, Dehkordi SK, Mathews JJ, Zare H, Xu P, Zhang B, Franklin C, Habes M, Craft S, Petersen RC, Tchkonia T, Kirkland JL, Salardini A, Seshadri S, Musi N, Orr ME. Gonzales MM, et al. Among authors: mathews jj. Nat Med. 2023 Oct;29(10):2481-2488. doi: 10.1038/s41591-023-02543-w. Epub 2023 Sep 7. Nat Med. 2023. PMID: 37679434 Free PMC article. Clinical Trial.
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Abbas HA, Hao D, Tomczak K, Barrodia P, Im JS, Reville PK, Alaniz Z, Wang W, Wang R, Wang F, Al-Atrash G, Takahashi K, Ning J, Ding M, Beird HC, Mathews JT, Little L, Zhang J, Basu S, Konopleva M, Marques-Piubelli ML, Solis LM, Parra ER, Lu W, Tamegnon A, Garcia-Manero G, Green MR, Sharma P, Allison JP, Kornblau SM, Rai K, Wang L, Daver N, Futreal A. Abbas HA, et al. Among authors: mathews jt. Nat Commun. 2021 Oct 18;12(1):6071. doi: 10.1038/s41467-021-26282-z. Nat Commun. 2021. PMID: 34663807 Free PMC article.
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
Shneider NA, Harms MB, Korobeynikov VA, Rifai OM, Hoover BN, Harrington EA, Aziz-Zaman S, Singleton J, Jamil A, Madan VR, Lee I, Andrews JA, Smiley RM, Alam MM, Black LE, Shin M, Watts JK, Walk D, Newman D, Pascuzzi RM, Weber M, Neuwirth C, Da Cruz S, Soriano A, Lane R, Henry S, Mathews J, Jafar-Nejad P, Norris D, Rigo F, Brown RH, Miller S, Crean R, Bennett CF. Shneider NA, et al. Among authors: mathews j. Lancet. 2025 Jun 7;405(10494):2075-2086. doi: 10.1016/S0140-6736(25)00513-6. Epub 2025 May 22. Lancet. 2025. PMID: 40414239
Investigation of the problematic knee replacement.
Murray JR, Howells N, Mathews JA, Kalson NS, Porteous AJ. Murray JR, et al. Among authors: mathews ja. Knee. 2020 Oct;27(5):1676-1680. doi: 10.1016/j.knee.2020.07.083. Epub 2020 Oct 2. Knee. 2020. PMID: 33012635 No abstract available.
Prescribing in pregnancy: navigating risks and benefits.
Dobson R, Ovadia C, Mathews J, Brex P. Dobson R, et al. Among authors: mathews j. Pract Neurol. 2023 Oct;23(5):366-367. doi: 10.1136/pn-2023-003812. Epub 2023 Jul 24. Pract Neurol. 2023. PMID: 37487704 No abstract available.
Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity.
McEvoy CM, Murphy JM, Zhang L, Clotet-Freixas S, Mathews JA, An J, Karimzadeh M, Pouyabahar D, Su S, Zaslaver O, Röst H, Arambewela R, Liu LY, Zhang S, Lawson KA, Finelli A, Wang B, MacParland SA, Bader GD, Konvalinka A, Crome SQ. McEvoy CM, et al. Among authors: mathews ja. Nat Commun. 2022 Dec 10;13(1):7634. doi: 10.1038/s41467-022-35297-z. Nat Commun. 2022. PMID: 36496458 Free PMC article.
Natural Killer Cell-Mediated Immunotherapy for Leukemia.
Allison M, Mathews J, Gilliland T, Mathew SO. Allison M, et al. Among authors: mathews j. Cancers (Basel). 2022 Feb 8;14(3):843. doi: 10.3390/cancers14030843. Cancers (Basel). 2022. PMID: 35159109 Free PMC article. Review.
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.
Aldoss I, Roloff GW, Faramand R, Kopmar NE, Lin C, Advani AS, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Zhang A, Miller K, Sutherland K, Dykes KC, Ahmed M, Chen E, Zambrano H, Bradshaw D, Mercadal S, Schwartz M, Tracy S, Dholaria B, Kubiak M, Mukherjee A, Majhail N, Battiwalla M, Mountjoy L, Malik SA, Mathews J, Shaughnessy P, Logan AC, Ladha A, Stefan M, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor M, O'Dwyer KM, Hill LC, Tsai SB, Sasine J, Solh MM, Lee CJ, Kota VK, Koura D, Veeraputhiran M, Blunk B, Oliai C, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Bishop MR, Stock W, Cassaday RD, Pullarkat V, Shah BD, Muffly LS. Aldoss I, et al. Among authors: mathews j. Blood Adv. 2024 Dec 10;8(23):6139-6147. doi: 10.1182/bloodadvances.2024013747. Blood Adv. 2024. PMID: 39093952 Free PMC article.
Cell therapy with human interleukin 10-producing ILC2s enhances islet function and inhibits allograft rejection.
Colpitts SJ, Jegatheeswaran S, Oakie A, Mashhouri S, Sachewsky N, Murshed H, Mathews JA, Reid KT, Misra PS, Fung VCW, Reichman TW, Nostro MC, Verchere CB, Levings MK, Crome SQ. Colpitts SJ, et al. Among authors: mathews ja. Am J Transplant. 2025 Sep;25(9):1858-1869. doi: 10.1016/j.ajt.2025.05.023. Epub 2025 May 23. Am J Transplant. 2025. PMID: 40412656 Free article.
1,000 results